Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021
Article
[키워드] absence
age
Anti-nucleocapsid antibodies
antibody
automatically
children
collected
conducted
confirmed COVID-19 case
contributed
COVID-19
COVID-19 case
COVID-19 pandemic
COVID-19 vaccination
CrI
cross-sectional
cumulative
estimate
Estimated
flow cytometric
IgG antibody
individual
Infection
Laboratory
National
Norway
nucleocapsid
nucleocapsid protein
Prevalence
RBD
Receptor binding domain
registry data
residual
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 seroprevalence
sera
seropositive sample
Seroprevalence
the spike protein
vaccination
vaccination.
were measured
women
[DOI] 10.1111/irv.13024 PMC 바로가기
[DOI] 10.1111/irv.13024 PMC 바로가기